A team of scientists over at MIT have developed a synthetic injectable that is designed to be able to reduce internal bleeding that can occur in the wake of major and traumatic injuries, potentially helping to buy time as patients are rushed to hospital for treatment.
This synthetic injectable makes use of a combination of polymers and nanoparticles that help to promote blood clots. The biological formation of blood clots takes place when platelets gather at wound sites to help foster clots, with fibrinogen proteins also playing a key role. The MIT system helps trigger this through the use of nanoparticles that attract platelets, and a special polymer that takes over the role of fibrinogen. Meanwhile, the synthetic injectable also features chemical technology that causes the nanoparticles to bind to the polymer, enabling efficient reactions.
The synthetic injectable has shown promise in mouse studies, and represents an innovative technique that could have the potential to save lives in the future once refined and tested for human use.
Image Credit: Christine Daniloff/MIT
Key Themes Behind This Trend
- Blood Clotting Synthetic Technology
- Synthetic injectables that use nanoparticles and polymers to promote blood clotting are a promising technology for reducing internal bleeding and saving lives.
- Nanoparticle-mediated Platelet Aggregation
- Nanoparticles that attract platelets and trigger clotting represent a groundbreaking solution for managing bleeding in trauma patients.
- Polymer-based Fibrinogen Replacement
- Polymers that mimic the role of fibrinogen in helping to clot blood offer a potential disruptive innovation for emergency medicine.
Where This Applies
- Medical Technology
- Medical technology companies specializing in emergency interventions and therapies for trauma patients can leverage this innovation to develop next-generation synthetic injectables.
- Pharmaceuticals
- Pharmaceutical companies that manufacture clotting agents and blood products can also explore potential applications and partnerships for this new technology.
- Emergency Services
- Emergency services providers, including ambulance and first response teams, can benefit from adopting this innovation for use in the field to help manage bleeding and increase patient survival rates.
